Imunon Investor Relations Material
Latest events
Q1 2025
Imunon
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Imunon Inc
Access all reports
Imunon Inc. is a clinical-stage biotechnology company focused on the development of innovative therapies for oncology and infectious diseases. The company utilizes its proprietary ThermoDox platform, which combines heat-activated liposomal drug delivery with targeted chemotherapy to enhance treatment effectiveness. Imunon also engages in the development of DNA-based vaccines and immunotherapies aimed at improving patient outcomes. The company is headquartered in Lawrenceville, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
IMNN
Country
🇺🇸 United States